A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

NCT00623116 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Kallmann Syndrome

Interventions

DRUG: Short withdrawal of testosterone, gonadotropins or estrogenic compounds (see below)

Sponsor

Hospital for Children and Adolescents, Finland